A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy
Clinical trial NCT00109265 · COMPLETED
Trial details
- NCT number
- NCT00109265
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.